Psoriasis in Australia: Symptoms, Types, and Treatment Options
%20Medium.jpeg)
Psoriasis is a chronic, immune-mediated inflammatory disease that primarily affects the skin, though it can also involve the joints and is associated with a range of other health conditions. At its core, psoriasis is caused by an overactive immune system that accelerates the life cycle of skin cells. In healthy skin, cells are produced deep in the epidermis and gradually migrate to the surface over a period of roughly 28 to 30 days, where they are shed. In psoriasis, this process is compressed dramatically. New skin cells are pushed to the surface in as few as three to four days, far faster than the body can shed them. The result is a build-up of cells on the skin's surface, forming the raised, thickened patches known as plaques.
These plaques are not simply cosmetic. They can be itchy, painful, and prone to cracking and bleeding. The silvery-white scales that characterise many forms of psoriasis are composed of dead skin cells that have accumulated because the turnover rate has outpaced the body's ability to manage them. The redness beneath reflects the inflammation driving the process.
Psoriasis is not contagious. It cannot be transmitted through touch, shared surfaces, or close contact. This is a point worth emphasising because the misconception persists, and it contributes to the stigma that many people with psoriasis experience. The Australasian College of Dermatologists notes that psoriasis affects approximately 2 to 3 per cent of the Australian population, making it one of the more common chronic skin conditions encountered in general practice.
It is also important to understand that psoriasis is a systemic condition, not just a skin disease. Research published in the Journal of the American Academy of Dermatology has established that people with psoriasis have a higher risk of developing cardiovascular disease, metabolic syndrome, type 2 diabetes, and inflammatory bowel disease. Psoriatic arthritis, which causes joint pain, stiffness, and swelling, affects up to 30 per cent of people with psoriasis. These associations underscore the importance of regular medical review and a GP who understands the full picture.
Psoriasis is not a single presentation. It encompasses several distinct types, each with characteristic features and patterns. Understanding the type is important because it informs the treatment approach.
Plaque Psoriasis
Plaque psoriasis is the most common form, accounting for approximately 80 to 90 per cent of all cases, according to DermNet. It presents as well-defined, raised patches of red or darkened skin covered with silvery-white scales. These plaques most commonly appear on the elbows, knees, lower back, and scalp, though they can develop anywhere on the body. They can range from small, isolated patches to large areas of involvement. On darker skin tones, plaques may appear more violet or brown rather than red, and this variation is important to recognise to avoid delayed diagnosis.
Plaque psoriasis tends to be symmetrical, meaning it often affects both sides of the body in similar locations. It is a chronic condition with a relapsing and remitting course. Flares may be triggered by stress, infection, injury to the skin, or certain medications.
Guttate Psoriasis
Guttate psoriasis presents as numerous small, drop-shaped lesions scattered across the trunk, arms, and legs. It is the second most common form and often appears suddenly, frequently following a streptococcal throat infection. The Australasian College of Dermatologists notes that guttate psoriasis is more common in children and young adults. For some people, it is a single episode that resolves within weeks to months. For others, it marks the beginning of chronic plaque psoriasis. A GP can help monitor the course and determine whether ongoing treatment is needed.
Inverse Psoriasis
Inverse psoriasis, also known as flexural psoriasis, affects the skin folds: the armpits, groin, under the breasts, and between the buttocks. Unlike plaque psoriasis, inverse psoriasis tends to appear as smooth, shiny, red patches without the typical silvery scales, because the moisture in skin folds prevents the characteristic scaling from forming. The location and appearance can sometimes lead to confusion with fungal infections or intertrigo, making accurate diagnosis by a GP particularly important.
Pustular Psoriasis
Pustular psoriasis is characterised by white, pus-filled blisters (pustules) surrounded by red or inflamed skin. It is important to note that these pustules are not infected and are not contagious. They contain white blood cells, not bacteria. Pustular psoriasis can be localised, most commonly affecting the palms and soles (palmoplantar pustulosis), or generalised across larger areas of the body. Generalised pustular psoriasis is a serious condition that can be accompanied by fever, chills, and severe illness. It requires urgent medical attention. Healthdirect Australia advises that anyone experiencing widespread pustular psoriasis should seek immediate medical care.
Erythrodermic Psoriasis
Erythrodermic psoriasis is the rarest and most severe form. It involves widespread, fiery redness and shedding of the skin across most of the body surface. It can disrupt the body's ability to regulate temperature and maintain fluid balance, and it is considered a medical emergency. Erythrodermic psoriasis may develop from poorly controlled plaque psoriasis, following abrupt withdrawal of systemic treatment, or as a reaction to severe sunburn or infection. It requires immediate hospital-based care. While rare, it is important to be aware of this form so that warning signs are recognised early.
The symptoms of psoriasis vary depending on the type and severity, but common features include raised, thickened patches of skin with silvery scales, redness or discolouration, itching or burning, dry skin that may crack and bleed, and nail changes such as pitting, thickening, or separation from the nail bed. Some people experience soreness or a tight feeling in the skin around affected areas. When psoriasis affects the scalp, it can extend beyond the hairline onto the forehead, behind the ears, and down the back of the neck.
Psoriasis is typically diagnosed clinically, meaning a GP can often make the diagnosis based on a careful examination of the skin and a thorough medical history. There is no single blood test for psoriasis. The appearance and distribution of the lesions, combined with information about family history and potential triggers, usually provide enough information for a confident diagnosis.
In some cases, particularly when the presentation is atypical or overlaps with other conditions such as eczema or fungal infections, a GP may arrange a skin biopsy. This involves taking a small sample of affected skin for examination under a microscope, which can confirm the diagnosis and rule out other conditions.
The RACGP's guidelines for skin conditions in general practice emphasise the importance of a full-body skin examination during the initial assessment. Psoriasis can affect areas that patients may not have noticed or may not feel comfortable raising, including the genital region, nails, and scalp. A thorough assessment helps the GP understand the extent of the condition and plan treatment accordingly.
It is also important for the diagnosing GP to ask about joint symptoms. Joint pain, stiffness, or swelling, particularly in the fingers, toes, lower back, or heels, may indicate psoriatic arthritis and warrants further investigation. Early detection and management of psoriatic arthritis can help prevent long-term joint damage.
Psoriasis is driven by a combination of genetic predisposition, immune system dysfunction, and environmental triggers. No single cause has been identified. Rather, the condition arises from a complex interplay of factors that vary from person to person.
The Immune System
At its foundation, psoriasis is an autoimmune condition. The immune system, specifically a type of white blood cell called a T cell, becomes overactive and triggers an inflammatory cascade in the skin. This inflammation accelerates the production of new skin cells, leading to the characteristic plaques. Research published in Nature Reviews Immunology has identified several key inflammatory pathways involved, including the interleukin-17 (IL-17) and interleukin-23 (IL-23) pathways, which have become important targets for modern biologic therapies.
Genetics
Family history is a significant risk factor. Psoriasis Australia notes that approximately one in three people with psoriasis has a close family member with the condition. Multiple genes have been linked to psoriasis susceptibility, with the HLA-Cw6 gene variant being one of the most strongly associated. However, having a genetic predisposition does not guarantee that psoriasis will develop. Many people carry the relevant genes without ever experiencing symptoms, which is where environmental triggers come into play.
Common Triggers
For people with a genetic predisposition, certain environmental or lifestyle factors can trigger or worsen psoriasis flares. Commonly recognised triggers include:
- Stress. Psychological stress is one of the most frequently reported triggers. The relationship between stress and psoriasis is bidirectional: stress can trigger flares, and living with psoriasis causes stress.
- Infections. Streptococcal throat infections are a well-established trigger for guttate psoriasis and can also exacerbate existing plaque psoriasis.
- Skin injury. The Koebner phenomenon describes the development of psoriasis at the site of skin trauma, such as cuts, scratches, sunburn, or even tattoos.
- Medications. Certain medications, including lithium, beta-blockers, antimalarials, and rapid withdrawal of systemic corticosteroids, can trigger or worsen psoriasis. The TGA's product information databases list these interactions, and a GP can review current medications as part of psoriasis management.
- Smoking and alcohol. Both are associated with an increased risk of developing psoriasis and with more severe disease. Reducing or ceasing smoking and moderating alcohol intake are commonly included in management plans.
- Climate and weather. Cold, dry weather tends to worsen psoriasis for many people, while moderate sun exposure can improve symptoms. Australia's climate is varied, and people living in cooler, drier regions may notice a seasonal pattern to their flares.
Understanding personal triggers is one of the most empowering aspects of psoriasis management. A GP who knows a patient's history can help identify patterns and develop strategies to reduce exposure to known triggers.
Psoriasis treatment in Australia follows a stepwise approach, starting with topical therapies for mild disease and progressing to more targeted systemic treatments as needed. The goal of treatment is not a cure, as no cure currently exists, but rather long-term control of symptoms, reduction in flare frequency, and improvement in quality of life.
Topical Treatments
For mild to moderate psoriasis, topical treatments are the first line of management. These are applied directly to the affected skin and include:
- Corticosteroids. Topical corticosteroids remain the most commonly prescribed treatment for psoriasis. They reduce inflammation, itch, and scaling. The potency is selected based on the location and severity. Mild formulations are used for sensitive areas such as the face and groin, while stronger preparations may be needed for thicker plaques on the elbows and knees. The Australasian College of Dermatologists advises that topical steroids are safe when used as directed and that under-treatment is a more common problem than over-treatment.
- Vitamin D analogues. Calcipotriol is the most widely used vitamin D analogue in Australia. It slows skin cell growth and can be used alone or in combination with a topical corticosteroid. Combination products (calcipotriol plus betamethasone) are available on the Pharmaceutical Benefits Scheme (PBS) and are a convenient first-line option.
- Coal tar preparations. Coal tar has been used to treat psoriasis for over a century. It helps reduce scaling, itching, and inflammation. While its mechanism of action is not fully understood, it remains an effective option for some patients, particularly for scalp psoriasis.
- Emollients. As with eczema, regular use of thick, fragrance-free moisturisers is a foundation of psoriasis care. Emollients help soften plaques, reduce scaling, and improve the effectiveness of other topical treatments.
Phototherapy
Phototherapy involves controlled exposure to ultraviolet (UV) light and is an effective treatment for moderate psoriasis that has not responded adequately to topical therapies alone. Narrowband UVB phototherapy is the most commonly used form in Australia and is available through dermatology clinics and some hospital outpatient departments. It works by slowing the growth of affected skin cells and modifying the immune response in the skin.
Phototherapy typically requires two to three sessions per week for a course of several weeks. It is generally well tolerated, though it requires a time commitment that can be challenging for some patients. A GP can arrange a referral for phototherapy when it is clinically appropriate.
Systemic Treatments
For moderate to severe psoriasis, or when topical and phototherapy options have been insufficient, systemic treatments may be considered. These are medications taken orally or by injection that work throughout the body to modify the immune response.
Conventional systemic agents used in Australia include methotrexate, ciclosporin, and acitretin. Each has a well-established evidence base and specific monitoring requirements. Methotrexate is one of the most commonly used systemic agents for psoriasis and is available on the PBS. It requires regular blood tests to monitor liver function and blood counts, and a GP plays a central role in ongoing monitoring even when the medication has been initiated by a specialist.
Biologic Therapies
Biologic medications represent the most significant advance in psoriasis treatment in recent decades. These are targeted therapies that block specific components of the immune system involved in psoriasis. In Australia, several biologics are approved and available on the PBS for eligible patients with moderate to severe psoriasis who have not responded to conventional treatments.
Key classes of biologics include TNF-alpha inhibitors (such as adalimumab and etanercept), IL-17 inhibitors (such as secukinumab and ixekizumab), and IL-23 inhibitors (such as guselkumab and risankizumab). The TGA regulates the approval of these medications, and access through the PBS requires assessment by a specialist dermatologist. The results achieved by many patients on biologics have been remarkable, with significant clearance of skin disease and improvement in quality of life reported in clinical trials published in the New England Journal of Medicine and The Lancet.
The pathway to biologic therapy begins with the GP. A referral to a dermatologist, along with documentation of previous treatments and their outcomes, is an essential first step. A GP who has maintained continuity with the patient and understands their treatment history can provide this documentation efficiently.
Psoriasis flaring up?
Psoriasis is a long-term condition, and learning to manage it well is a process that evolves over time. Flares will happen. The goal is to reduce their frequency, manage them effectively when they occur, and minimise the broader impact on daily life.
Maintain a consistent skincare routine. Daily moisturising with a thick, fragrance-free emollient helps keep the skin hydrated, reduces scaling, and may extend the time between flares. Bathing in lukewarm water with soap-free wash products and patting the skin dry rather than rubbing are small habits that support the skin barrier over time.
Track personal triggers. Keeping a simple record of flare-ups alongside potential triggers, such as periods of high stress, illness, weather changes, or medication changes, can reveal patterns that inform management. A GP can review this information and adjust the treatment plan accordingly.
Manage stress proactively. Given the well-documented relationship between psychological stress and psoriasis flares, stress management is a practical component of care, not an afterthought. Regular physical activity, adequate sleep, and structured relaxation techniques have all been associated with improved outcomes in people with psoriasis. For those experiencing significant anxiety or depression, a mental health care plan arranged through a GP can provide access to subsidised psychology sessions.
Avoid known irritants. Harsh soaps, fragrances, and tight-fitting clothing over affected areas can worsen symptoms. Alcohol and smoking are modifiable risk factors that have a measurable impact on disease severity.
Stay engaged with treatment. One of the most common reasons for poor psoriasis outcomes is treatment fatigue. Applying topical treatments daily, attending follow-up appointments, and managing prescriptions require effort. Building a relationship with a GP who understands the condition and the patient's circumstances makes it easier to stay on track and adjust the plan when needed.
Address the emotional toll. Psoriasis carries a significant psychological burden. A study published in the British Journal of Dermatology found that people with psoriasis report higher rates of depression, anxiety, and social withdrawal compared with the general population. The visibility of the condition, combined with misconceptions about contagiousness, can affect self-esteem and social interactions. Speaking openly with a GP about the emotional impact is an important part of comprehensive care.
Psoriasis is a condition that benefits from regular, ongoing medical care. Flares need to be assessed, treatment plans adjusted, triggers discussed, and referrals arranged when the condition requires specialist input. For many Australians, particularly those in regional or rural areas, those balancing work and family commitments, or those who have struggled to find a regular GP, accessing this kind of continuous care has been genuinely difficult.
Abby Health is an online-first clinic offering GP consultations seven days a week, 365 days a year, through a care network of more than 300 clinicians. Consultations can be bulk billed for eligible patients with a valid Medicare card. The clinic is designed around the principle that patients should be able to see the same GP over time, building a relationship where the clinician understands the patient's condition, history, and goals. The 71 per cent rebook rate reflects this: three in four patients choose to return to the same doctor.
For psoriasis, this continuity matters. A GP who knows which topical treatments have been tried, how the patient's skin has responded, whether joint symptoms have developed, and what triggers have been identified can make more informed decisions at each consultation. Each appointment builds on the last rather than starting from scratch.
Abby AI, the clinic's medical AI, supports each consultation by surfacing relevant patient history, previous prescriptions, test results, and clinical notes so the GP arrives informed. It does not diagnose or prescribe. It ensures the clinician has the full picture, so the conversation can focus on what matters most.
During a psoriasis consultation, a GP can:
- Assess the current presentation via video and uploaded photos
- Review treatment history and discuss what has and has not worked
- Prescribe topical treatments, including corticosteroids and vitamin D analogues, with electronic prescriptions sent directly to the patient's preferred pharmacy
- Arrange referrals to dermatologists for phototherapy, systemic treatment, or biologic therapy assessment
- Discuss triggers, lifestyle modifications, and long-term management strategies
- Address associated conditions, including joint symptoms, mental health impacts, and cardiovascular risk factors
For a condition that requires ongoing attention and benefits from a clinician who understands the full story, an online-first clinic built around continuity of care is a practical and meaningful option.
Editorial Standards
Notice something that doesn’t look right? Let us know at support@abbyhealth.app
Authors
.avif)
